StartOPL • ASX
add
Opyl Ltd
Seneste lukkekurs
0,026 $
Årsinterval
0,014 $ - 0,033 $
Markedsværdi
4,52 mio. AUD
Gns. volumen
147,09 t
P/E-værdi
-
Udbytteprocent
-
Primær børs
ASX
I nyhederne
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
(AUD) | dec. 2024info | År til år-ændring |
---|---|---|
Indtægt | 21,07 t | -82,70 % |
Driftsudgifter | 176,95 t | -22,08 % |
Nettoindtægt | -341,60 t | 46,47 % |
Overskudsgrad | -1,62 t | -209,51 % |
Earnings per share | — | — |
EBITDA | -318,25 t | 25,33 % |
Effektiv afgiftssats | — | — |
Årsbalance
Samlede aktiver
Samlede passiver
(AUD) | dec. 2024info | År til år-ændring |
---|---|---|
Kontanter og korttidsinvesteringer | 329,55 t | -43,64 % |
Samlede aktiver | 384,82 t | -41,63 % |
Samlede passiver | 695,82 t | -3,76 % |
Samlet egenkapital | -310,99 t | — |
Shares outstanding | 192,86 mio. | — |
Kurs/indre værdi | ∞ | — |
Afkast af aktiver | -208,60 % | — |
Afkast af kapital | -683,65 % | — |
Pengestrøm
Nettoændring i likviditet
(AUD) | dec. 2024info | År til år-ændring |
---|---|---|
Nettoindtægt | -341,60 t | 46,47 % |
Pengestrøm fra drift | -309,99 t | -6,88 % |
Pengestrøm fra investering | -662,00 | — |
Pengestrøm fra finansiering | 288,10 t | -19,06 % |
Nettoændring i likviditet | -22,55 t | -134,21 % |
Fri pengestrøm | -200,88 t | 17,96 % |
Om
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Grundlagt
2013
Website
Ansatte
3